Literature DB >> 5020715

Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.

A Redfors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5020715      PMCID： PMC458489          DOI： 10.1136/hrt.34.4.383

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  23 in total

Review 1.  The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.

Authors:  H Lüllmann; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1969-01       Impact factor: 3.765

Review 2.  Current concepts of membrane structure and function.

Authors:  E D Korn
Journal:  Fed Proc       Date:  1969 Jan-Feb

3.  Assay of digitalis concentrations in blood.

Authors:  F I Marcus
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

4.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

5.  An improved method of digoxin therapy.

Authors:  R W Jelliffe
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

6.  Intensive hospital monitoring of adverse reactions to drugs.

Authors:  N Hurwitz; O L Wade
Journal:  Br Med J       Date:  1969-03-01

7.  An improved method for measuring plasma and tissue concentrations of digitalis glycosides.

Authors:  J M Lowenstein; E M Corrill
Journal:  J Lab Clin Med       Date:  1966-06

8.  Influence of potassium depletion on myocardial concentration of tritiated digoxin.

Authors:  K E Cohn; R E Kleiger; D C Harrison
Journal:  Circ Res       Date:  1967-05       Impact factor: 17.367

9.  Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Authors:  F I Marcus; L Burkhalter; C Cuccia; J Pavlovich; G G Kapadia
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

10.  Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.

Authors:  D G Grahame-Smith
Journal:  Br Med J       Date:  1969-02-01
View more
  31 in total

1.  The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.

Authors:  A Taylor; A Beerahee; D Citerone; M Davy; K Fitzpatrick; A Lopez-Gil; F Stocchi
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.

Authors:  B F Johnson; C Bye
Journal:  Br Heart J       Date:  1975-02

Review 3.  ABC of monitoring drug therapy. Digoxin.

Authors:  J K Aronson; M Hardman
Journal:  BMJ       Date:  1992-11-07

Review 4.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

5.  Absorption of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

6.  Oral digitalisation: choice of dose.

Authors:  S M Dobbs; J Parkes; E M Rodgers; W I Kenyon
Journal:  Br Med J       Date:  1977-07-16

7.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

9.  Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Authors:  D J Sumner; A J Russell
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.

Authors:  D Boerner; A Olcay; W Schaumann; W Weiss
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.